Exelixis (EXEL) Insider Trading & Ownership $35.30 -0.72 (-2.00%) As of 01/13/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Exelixis (NASDAQ:EXEL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage2.85%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$12.67 MNumber OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$21.62 M Get EXEL Insider Trade Alerts Want to know when executives and insiders are buying or selling Exelixis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EXEL Insider Buying and Selling by Quarter Exelixis Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/29/2024Jeffrey HessekielEVPSell60,000$36.67$2,200,200.00 11/22/2024Patrick J HaleyEVPSell10,000$35.27$352,700.00 11/18/2024Patrick J HaleyEVPSell41,588$34.36$1,428,963.68 11/5/2024Dana AftabEVPSell96,986$35.00$3,394,510.00 11/1/2024George PosteDirectorSell30,000$34.00$1,020,000.00 11/1/2024Jeffrey HessekielEVPSell50,000$34.13$1,706,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/30/2024Dana AftabEVPSell1,162$31.40$36,486.80 10/28/2024Jeffrey HessekielEVPSell25,000$28.39$709,750.00 9/23/2024Jeffrey HessekielEVPSell25,000$26.38$659,500.00 8/26/2024Jeffrey HessekielEVPSell20,000$25.79$515,800.00 8/14/2024Maria C FreireDirectorSell8,250$26.56$219,120.00 8/12/2024Dana AftabEVPSell20,883$27.06$565,093.98 8/9/2024Christopher J SennerCFOSell125,000$27.19$3,398,750.00 8/8/2024George PosteDirectorSell33,725$26.89$906,865.25 8/7/2024Dana AftabEVPSell95,000$25.00$2,375,000.00 6/4/2024Jack L WyszomierskiDirectorSell8,287$22.00$182,314.00 5/30/2024David Edward JohnsonDirectorBuy225,000$20.76$4,671,000.00 5/28/2024David Edward JohnsonDirectorBuy200,000$20.32$4,064,000.00 5/21/2024George PosteDirectorSell11,686$20.96$244,938.56 5/13/2024Jack L WyszomierskiDirectorSell10,923$21.37$233,424.51 3/21/2024Alan M GarberDirectorSell19,205$24.01$461,112.05 2/23/2024Patrick J HaleyEVPSell47,020$21.45$1,008,579.00 2/21/2024David Edward JohnsonDirectorBuy190,000$20.70$3,933,000.00 (Data available from 1/1/2013 forward) EXEL Insider Trading Activity - Frequently Asked Questions Who is on Exelixis's Insider Roster? The list of insiders at Exelixis includes Alan M Garber, Carl B Feldbaum, Christopher J Senner, Dana Aftab, David Edward Johnson, George Poste, Jack L Wyszomierski, Jeffrey Hessekiel, Lance Willsey, Maria C Freire, Patrick J Haley, Peter Lamb, and Stelios Papadopoulos. Learn more on insiders at EXEL. What percentage of Exelixis stock is owned by insiders? 2.85% of Exelixis stock is owned by insiders. Learn more on EXEL's insider holdings. Which Exelixis insiders have been buying company stock? The following insider purchased EXEL shares in the last 24 months: David Edward Johnson ($15,270,038.49). How much insider buying is happening at Exelixis? Insiders have purchased a total of 735,409 EXEL shares in the last 24 months for a total of $15,270,038.49 bought. Which Exelixis insiders have been selling company stock? The following insiders have sold EXEL shares in the last 24 months: Alan M Garber ($1,160,712.05), Carl B Feldbaum ($711,200.00), Christopher J Senner ($4,629,350.00), Dana Aftab ($6,474,627.78), George Poste ($2,171,803.81), Jack L Wyszomierski ($669,871.51), Jeffrey Hessekiel ($10,099,818.40), Maria C Freire ($219,120.00), and Patrick J Haley ($5,341,875.69). How much insider selling is happening at Exelixis? Insiders have sold a total of 1,241,827 Exelixis shares in the last 24 months for a total of $31,478,379.24 sold. Exelixis Key ExecutivesDr. Stelios Papadopoulos Ph.D. (Age 76)Co-Founder & Chair of the Board Compensation: $118.25kDr. Michael M. Morrissey Ph.D. (Age 63)CEO, President & Director Compensation: $2.16MMr. Christopher J. Senner (Age 56)Executive VP & CFO Compensation: $1.06M1 recent tradesDr. Dana T. Aftab Ph.D. (Age 60)Executive VP of Discovery and Translational Research & Chief Scientific Officer Compensation: $883.03kMr. Jeffrey J. Hessekiel J.D. (Age 55)Executive VP, General Counsel & Secretary Compensation: $933.08k5 recent tradesDr. Amy C. Peterson M.D. (Age 57)Executive VP, Product Development & Medical Affairs and Chief Medical Officer Compensation: $568.85kMs. Susan T. HubbardExecutive Vice President of Public Affairs & Investor RelationsMs. Laura DillardExecutive Vice President of Human ResourcesDr. Anne Champsaur M.D.Senior Vice President of Drug SafetyDr. William Berg M.D.Senior Vice President of Medical Affairs More Insider Trading Tools from MarketBeat Related Companies Alnylam Pharmaceuticals Insider Trades Biogen Insider Trades United Therapeutics Insider Trades Incyte Insider Trades Neurocrine Biosciences Insider Trades BioMarin Pharmaceutical Insider Trades Exact Sciences Insider Trades Repligen Insider Trades Madrigal Pharmaceuticals Insider Trades Halozyme Therapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher This page (NASDAQ:EXEL) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersGreatest crypto bull market in history?A crypto storm is coming Right now, conditions are in place for a historic move we expect will be the great...Stansberry Research | Sponsored$24 trillion tech spotted at Mar-a-Lago?President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…Centurion Publishing | SponsoredTrump’s 2nd Term Shocker: New AI ComingForget Nvidia. Legendary investor Louis Navellier is recommending this little-known company because it's he...10 Minute Trades | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Elon Spotted at Weird Facility in Memphis? What Elon Musk is planning at a remote facility in Memphis may be his greatest achievement to date. Because...Paradigm Press | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exelixis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exelixis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
